Related Experiment Video
Updated: Mar 2, 2026

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
957
Predicting prognosis in patients with advanced cancer: A prospective study
Teresa Tavares1, Margarida Oliveira1, João Gonçalves2
11 Unidade Local de Saúde de Matosinhos, Matosinhos, Portugal.
Palliative Medicine
|May 11, 2017
Summary
Young doctors often inaccurately predict patient survival. Using prognostic scores, like the Palliative Prognostic score, alongside expert clinical prediction significantly improves survival prediction accuracy in advanced cancer patients.
Area of Science:
- Palliative Care
- Oncology
- Medical Prognosis
Background:
- Accurate prognosis is crucial for patient care, clinical decisions, and ethical considerations in medicine.
- Physicians face significant challenges in predicting patient survival accurately.
Purpose of the Study:
- To evaluate the accuracy of young doctors' clinical survival predictions.
- To assess the utility of expert opinion, Palliative Prognostic score, and Palliative Prognostic Index in improving survival predictions.
Main Methods:
- Prospective, observational study involving 38 advanced cancer patients.
- Comparison of young doctors' predictions with palliative care experts' predictions and validated prognostic scores.
- Analysis of prediction accuracy and error severity.
Main Results:
- Young doctors' predictions were adequate in only 10.5% of cases, with frequent optimistic errors.
- Palliative care experts showed improved accuracy (23.7%) and fewer severe errors.
- Palliative Prognostic score (47% adequate) and Palliative Prognostic Index (55% adequate) demonstrated superior performance.
- The Palliative Prognostic score, when used by experts, showed the strongest correlation with observed survival (r=-0.629, p<0.01).
Conclusions:
- Young doctors' clinical survival predictions are frequently inadequate.
- Prognostic scores, particularly the Palliative Prognostic score, significantly enhance prediction accuracy.
- Combining clinical prediction with validated prognostic scores is recommended for improved survival forecasting in palliative care.
Related Concept Videos
Cancer Survival Analysis
805
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
805
Kaplan-Meier Approach
663
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
663
Tumor Progression
7.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.6K
Comparing the Survival Analysis of Two or More Groups
674
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
674
Actuarial Approach
339
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
339
